Cargando…
Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea
The effects of neonatal immunization with 7-valent pneumococcal conjugate vaccine (7vPCV) on development of T-cell memory and general immune maturation were studied in a cohort of Papua New Guinean newborns. Neonatal 7vPCV priming (followed by a dose at 1 and 2 months of age) was associated with enh...
Autores principales: | van den Biggelaar, Anita. H.J., Richmond, Peter C., Pomat, William S., Phuanukoonnon, Suparat, Nadal-Sims, Marie A., Devitt, Catherine J., Siba, Peter M., Lehmann, Deborah, Holt, Patrick G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697326/ https://www.ncbi.nlm.nih.gov/pubmed/19150378 http://dx.doi.org/10.1016/j.vaccine.2008.12.046 |
Ejemplares similares
-
Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance
por: van den Biggelaar, Anita H.J., et al.
Publicado: (2011) -
Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial
por: Pomat, William S., et al.
Publicado: (2013) -
Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
por: Orami, Tilda, et al.
Publicado: (2020) -
Cord blood Streptococcus pneumoniae‐specific cellular immune responses predict early pneumococcal carriage in high‐risk infants in Papua New Guinea
por: Francis, J. P., et al.
Publicado: (2016) -
An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea
por: Javati, Sarah, et al.
Publicado: (2020)